A nano-immunomodulator modified with N -acetylgalactosamine (GalNAc) on calcium carbonate (CaCO 3 ) was prepared for targeted and responsive immunotherapy. And the immunologic adjuvant (CpG ODNs) and doxorubicin (DOX) were released to synergistically improve immune response for treating orthotopic liver cancer.